How the Timing of Annual COVID-19 Vaccination of Nursing Home Residents and Staff Affects Its Value
- PMID: 38432644
- PMCID: PMC10990766
- DOI: 10.1016/j.jamda.2024.02.005
How the Timing of Annual COVID-19 Vaccination of Nursing Home Residents and Staff Affects Its Value
Abstract
Objectives: To evaluate the epidemiologic, clinical, and economic value of an annual nursing home (NH) COVID-19 vaccine campaign and the impact of when vaccination starts.
Design: Agent-based model representing a typical NH.
Setting and participants: NH residents and staff.
Methods: We used the model representing an NH with 100 residents, its staff, their interactions, COVID-19 spread, and its health and economic outcomes to evaluate the epidemiologic, clinical, and economic value of varying schedules of annual COVID-19 vaccine campaigns.
Results: Across a range of scenarios with a 60% vaccine efficacy that wanes starting 4 months after protection onset, vaccination was cost saving or cost-effective when initiated in the late summer or early fall. Annual vaccination averted 102 to 105 COVID-19 cases when 30-day vaccination campaigns began between July and October (varying with vaccination start), decreasing to 97 and 85 cases when starting in November and December, respectively. Starting vaccination between July and December saved $3340 to $4363 and $64,375 to $77,548 from the Centers for Medicare & Medicaid Services and societal perspectives, respectively (varying with vaccination start). Vaccination's value did not change when varying the COVID-19 peak between December and February. The ideal vaccine campaign timing was not affected by reducing COVID-19 levels in the community, or varying transmission probability, preexisting immunity, or COVID-19 severity. However, if vaccine efficacy wanes more quickly (over 1 month), earlier vaccination in July resulted in more cases compared with vaccinating later in October.
Conclusions and implications: Annual vaccination of NH staff and residents averted the most cases when initiated in the late summer through early fall, at least 2 months before the COVID-19 winter peak but remained cost saving or cost-effective when it starts in the same month as the peak. This supports tethering COVID vaccination to seasonal influenza campaigns (typically in September-October) for providing protection against SARS-CoV-2 winter surges in NHs.
Keywords: COVID-19; Nursing homes; SARS-CoV-2; annual vaccination; cost-effectiveness; economic.
Copyright © 2024 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure The authors declare no conflicts of interest.
Similar articles
-
Modeling Nursing Home Harms From COVID-19 Staff Furlough Policies.JAMA Netw Open. 2024 Aug 1;7(8):e2429613. doi: 10.1001/jamanetworkopen.2024.29613. JAMA Netw Open. 2024. PMID: 39158906 Free PMC article.
-
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1163-1166. doi: 10.15585/mmwr.mm7034e3. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34437519 Free PMC article.
-
Cost-effectiveness of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) testing and isolation strategies in nursing homes.Infect Control Hosp Epidemiol. 2024 Jun;45(6):754-761. doi: 10.1017/ice.2024.9. Epub 2024 Feb 15. Infect Control Hosp Epidemiol. 2024. PMID: 38356377 Free PMC article.
-
Association of COVID-19 Vaccination Rates of Staff and COVID-19 Illness and Death Among Residents and Staff in US Nursing Homes.JAMA Netw Open. 2022 Dec 1;5(12):e2249002. doi: 10.1001/jamanetworkopen.2022.49002. JAMA Netw Open. 2022. PMID: 36580329 Free PMC article.
-
De-escalation of asymptomatic testing and potential of future COVID-19 outbreaks in US nursing homes amidst rising community vaccination coverage: A modeling study.Vaccine. 2022 May 20;40(23):3165-3173. doi: 10.1016/j.vaccine.2022.04.040. Epub 2022 Apr 18. Vaccine. 2022. PMID: 35487811 Free PMC article.
Cited by
-
Modeling Nursing Home Harms From COVID-19 Staff Furlough Policies.JAMA Netw Open. 2024 Aug 1;7(8):e2429613. doi: 10.1001/jamanetworkopen.2024.29613. JAMA Netw Open. 2024. PMID: 39158906 Free PMC article.
References
-
- U.S. Food and Drug Administration. Updated COVID-19 Vaccines for Use in the United States Beginning in Fall 2023. https://www.fda.gov/vaccines-blood-biologics/updated-covid-19-vaccines-u.... Published 2023. Accessed.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
